Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
Neurotherapeutics - United States
doi 10.1007/s13311-015-0402-6
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2015
Authors
Publisher
Springer Science and Business Media LLC